Investment Rating - The investment rating for the company is "Buy" and is maintained [7]. Core Views - The company is a rare diversified real estate developer in China, with significant advantages in its business model. It has leading capabilities in development, finance, operations, and branding, along with ample and well-structured land reserves to ensure future sales scale. The pressure from impairments has been relatively well-released, and the profit margins from newly acquired land are attractive, indicating a high degree of performance solidity and realization [5][8]. - As a leader in the commercial sector, the company excels in various dimensions such as layout, leasing, operations, rental income, efficiency, and luxury retail. The commercial REITs facilitate asset exit channels, and high-quality self-owned assets provide stable cash flow to help navigate through cycles, which can also enhance the company's dividend and valuation potential [5][8]. Summary by Sections Financial Performance - In the first half of 2025, the company reported revenue of 94.9 billion (up 19.9%) and a net profit attributable to shareholders of 11.9 billion (up 16.2%). The core net profit was 10 billion (down 6.6%), with a comprehensive gross margin of 24.0% (up 1.8 percentage points). The interim dividend per share was 0.2 HKD, with a payout ratio of 14.3% relative to core earnings [5][8]. - Revenue and profitability improvements are driving performance growth, with a stable outlook for the future. The company’s total sales for the first half of 2025 were 110.3 billion (down 11.6%), ranking third in the industry, with a sales area of 4.119 million square meters (down 21.0%) and an average selling price of 27,000 HKD per square meter (up 11.9%) [8]. Land Acquisition and Sales - The company remains in the top tier for sales, with robust investments and ample land reserves ensuring future sales stability. In the first half of 2025, the company acquired 18 projects with a total land acquisition amount of 44.73 billion (up 74.7%) and a land area of 1.482 million square meters (down 26.8%). The average land price was 30,000 HKD per square meter (up 138.5%) [8]. - As of the first half of 2025, the company had a developable land reserve of 41.19 million square meters, with 70% located in first and second-tier cities, ensuring stable future sales [8]. Commercial Operations - The company is a leader in commercial operations, with both retail sales and occupancy rates showing growth. In the first half of 2025, shopping center retail sales reached 110.1 billion (up 20.2%), with luxury and non-luxury segments growing by 13.3% and 24.9%, respectively. The same-store sales growth rate was 9.4%, and the occupancy rate improved to 97.3% [8]. - Rental income for the first half of 2025 was 10.4 billion (up 9.9%), with a decrease in selling and administrative expense ratio to 12.1%, leading to an operating profit margin of 65.9%, showcasing industry-leading operational efficiency [8]. Investment Recommendations - The company is positioned as a rare diversified real estate developer with clear business model advantages. It is expected that the net profit attributable to shareholders will reach 26.2 billion, 27 billion, and 28.2 billion for 2025-2027, representing year-on-year growth of 2%, 3%, and 5%, respectively. The corresponding price-to-earnings ratios are projected to be 7.6, 7.4, and 7.0 times [5][8].

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company reported a significant decline in revenue and net profit for the first half of 2025, with revenue at 5.799 billion yuan, down 42.85% year-on-year, and net profit at 639 million yuan, down 69.52% year-on-year [2][4]. - The second quarter of 2025 saw revenue of 2.661 billion yuan, a decrease of 52.8% year-on-year and 15.19% quarter-on-quarter, with net profit dropping to 66 million yuan, down 93.56% year-on-year and 88.46% quarter-on-quarter [2][4]. - Despite the downturn, the company achieved a positive operating cash flow of 447 million yuan, an increase of 55.84% year-on-year [2][4]. Summary by Sections Financial Performance - In 2025H1, the company's revenue and net profit experienced substantial declines, with specific figures indicating a 42.85% drop in revenue and a 69.52% drop in net profit compared to the previous year [2][4]. - The gross profit margin for 2025H1 was 24.38%, down 12.62 percentage points year-on-year, with equipment and service margins at 32.93% and materials at 6.22%, reflecting declines in both segments [2][4]. Business Segments - The equipment and service segment faced order and acceptance delays, while the semiconductor equipment segment benefited from accelerated domestic production, with an order backlog exceeding 3.7 billion yuan at the end of Q2 2025 [2][4]. - The company successfully secured bulk orders for 8-inch silicon carbide from international clients, expected to ramp up production next year, and improved its market share in photovoltaic crucibles [2][4]. Future Outlook - The company is focusing on enhancing its technological capabilities and operational quality during the industry downturn, with plans to expand its product offerings in the semiconductor and photovoltaic sectors [2][4]. - Forecasts for 2025 and 2026 project net profits of 1.5 billion yuan and 1.75 billion yuan, respectively, with corresponding price-to-earnings ratios of 27 and 23 [2][4].

丨证券研究报告丨 [Table_Author] 徐科 王筱茜 叶之楠 盛意 SAC：S0490517090001 SAC：S0490519080004 SAC：S0490520090003 SAC：S0490525070006 SFC：BUV415 SFC：BWM115 联合研究丨公司点评丨龙净环保（600388.SH） [Table_Title] 龙净环保 2025H1 点评：Q2 归母净利润同比增 12.0%，H1 清洁能源净利润近亿元 报告要点 [Table_Summary] 龙净环保发布 2025 年中报， Q2 实现营收 27.18 亿元，同比增 13.5%；归母净利润 2.60 亿 元，同比增 12.0%。上半年烟气治理业务收入确认存波动（预计全年维度将实现相对稳健）、毛 利率上行；清洁能源净利润近亿元，海内外项目有序快速推进；储能开始盈利，矿山装备快速 形成能力。公司持续推进业务提质增效，主业毛利率稳步上行，现金流预计向好，有息负债率 保持低位，紫金持续增持、赋能，看好公司长期发展。 分析师及联系人 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [8]. Core Views - The company achieved a revenue of 20.509 billion yuan in H1 2025, representing a year-on-year growth of 26.73%. The net profit attributable to the parent company was 2.968 billion yuan, up 40.15% year-on-year [2][5]. - The revenue for Q2 2025 was 11.531 billion yuan, with a year-on-year increase of 18.99%. The net profit attributable to the parent company for the same period was 1.646 billion yuan, reflecting a year-on-year growth of 25.91% [2][5]. - The rapid growth in revenue is driven by the new energy vehicle sector, while the general automation business remains stable. The overseas business is accelerating, with overseas revenue increasing by 39.34% year-on-year [2][10]. Summary by Sections Financial Performance - In H1 2025, the company reported a net profit of 2.968 billion yuan, a 40.15% increase year-on-year, and a non-recurring net profit of 2.671 billion yuan, up 29.15% year-on-year [2][5]. - The gross margin for the general automation business improved by 0.71 percentage points to 44.51%, while the gross margin for new energy vehicles and rail transit increased by 0.14 percentage points to 17.45% [10]. Business Segments - The company's revenue from general automation and new energy vehicles grew by 17% and 50% year-on-year, respectively. The overseas revenue accounted for 6.4% of total revenue [10]. - The market share for core products in the industrial automation sector is steadily increasing, with the company holding the top position in several product categories [10]. Future Outlook - The company is focusing on enhancing its market share and expanding into new business areas and overseas markets. It is expected to achieve net profits of 5.52 billion yuan, 7.15 billion yuan, and 8.60 billion yuan for the years 2025 to 2027, corresponding to P/E ratios of 36, 28, and 23 times [10].

丨证券研究报告丨 公司研究丨点评报告丨黄山旅游（600054.SH） [Table_Title] 2025 年中报点评：进山游客稳健增长 报告要点 [Table_Summary] 全域布局全力推进，科技引领持续发力，2025 年黄山 AI 旅行助手全面接入 DeepSeek 大模 型，在智能交互、场景服务、伴游体验等方面迎来全面升级。看好公司受益于交通条件改善、 酒店项目改造等多重利好，实现收入业绩稳增。在 2024 年，池黄高铁开通，随着天气条件改 善，未来进山客流有望进一步增长；山上山下酒店改造升级，量价有望重攀高峰。预计 2025- 2027 年公司归母净利润分别为 3.54/3.93/4.36 亿元，对应 PE 分别为 25/22/20X，维持"买 入"评级。 分析师及联系人 [Table_Author] 赵刚 杨会强 马健轩 SAC：S0490517020001 SAC：S0490520080013 SFC：BUX176 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 黄山旅游（600054.SH） cjzqdt11111 [Table_Title2] ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [7]. Core Insights - In the first half of 2025, the company achieved significant revenue growth, with total revenue reaching 5.953 billion yuan, a year-on-year increase of 50.6%. The NON-IFRS net profit was 1.213 billion yuan, and the gross margin improved to 86.8%, up 2.7% year-on-year [2][4][6]. - The company has a robust pipeline with five innovative products approved in the oncology and comprehensive fields, driving revenue growth. The clinical pipeline is rich, supporting a sustainable development model [2][4][6]. - The company is accelerating its global strategy, with the second-generation IO potential product IBI363 set to initiate global Phase III clinical trials. The company is also advancing its clinical pipeline globally, including IBI343 for pancreatic and gastric cancer [6][8]. - The company expects to achieve a net profit of 591 million yuan, 1.177 billion yuan, and 2.313 billion yuan for the years 2025 to 2027, with corresponding EPS of 0.34 yuan, 0.69 yuan, and 1.35 yuan [6][8]. Summary by Sections Financial Performance - In the first half of 2025, the company reported total revenue of 5.953 billion yuan, with product revenue at 5.234 billion yuan, reflecting a year-on-year increase of 37.3%. The NON-IFRS net profit was 1.213 billion yuan, and EBITDA was 1.413 billion yuan. The company had cash reserves of approximately 14.6 billion yuan as of July 31, 2025, with R&D investment amounting to 903 million yuan [2][4][8]. Product Pipeline and Development - The company has a total of 16 commercialized products and 21 clinical pipelines. In the oncology sector, three products were approved in the first half of 2025, including a ROS1 inhibitor and a third-generation EGFR TKI. In the comprehensive field, two products were approved, including a dual-target weight loss drug [6][8].

Investment Rating - The report maintains a "Buy" rating for the company [9] Core Views - In the first half of 2025, the company reported revenue of 28.151 billion yuan, a year-on-year decrease of 9.96%, and a net profit attributable to shareholders of 2.6 billion yuan, down 20.81% year-on-year [2][6] - For the second quarter alone, revenue was 11.405 billion yuan, a decline of 8.45% year-on-year, with a net profit of 662 million yuan, down 32.21% year-on-year [2][6] - The company is expected to achieve net profits attributable to shareholders of 4.292 billion yuan, 4.364 billion yuan, and 4.520 billion yuan for 2025, 2026, and 2027 respectively, corresponding to current price-to-earnings ratios of 33.22, 32.67, and 31.54 [2][6] Revenue Analysis - Revenue from Hainan and Shanghai showed declines, with Hainan's revenue at 15.031 billion yuan (down 10.45% year-on-year) and Shanghai's at 6.870 billion yuan (down 19.18% year-on-year) [6] - The company's market share in Hainan's duty-free sector increased by nearly 1 percentage point, indicating strong operational capabilities despite overall revenue declines [6] - Duty-free revenue was 20.343 billion yuan (down 6.13% year-on-year), while taxable revenue was 7.189 billion yuan (down 21.50% year-on-year) [6] Profitability Insights - The overall gross margin slightly decreased to 32.8%, down 0.8 percentage points year-on-year, while the net profit margin was 10.3%, down 1.3 percentage points year-on-year [6] - The increase in expenses was noted, with sales, management, and R&D expenses showing slight increases [6] Industry Outlook - The duty-free and tourism retail sectors are expected to benefit from the positive outlook of the tourism industry, which is a significant part of China's economy and a key driver of domestic demand [6] - The company is positioned as a leading player in the duty-free industry, leveraging its advantages in channels, scale, and brand management [6]

丨证券研究报告丨 赵刚 杨会强 马健轩 SAC：S0490517020001 SAC：S0490520080013 SFC：BUX176 公司研究丨点评报告丨锦江酒店（600754.SH） [Table_Title] 2025 年半年度报告点评：公司降本成效明显， 门店保持稳健增长 报告要点 [Table_Summary] 2025 年上半年，公司实现营业收入 65.26 亿元，同比下降 5.31%，实现归母净利润 3.71 亿元， 同比下降 56.27%，扣非归母净利润 4.09 亿元，同比增长 5.17%。展望未来，短期内，公司延 续较高开店计划，预计 2025 年新增开业酒店 1300 家，新增签约酒店 2000 家，中长期看好公 司"12+3+1"品牌发展战略。预计 2025-2027 年公司归母净利润分别为 10.48、13.01、14.99 亿元，对应 PE 分别为 23/19/16X，维持"买入"评级。 分析师及联系人 [Table_Author] 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 锦江酒店（600754.SH） cjzqdt1111 ...

Investment Rating - The report maintains a "Buy" rating for the company [7] Core Views - In the first half of 2025, the company achieved operating revenue of 1.991 billion yuan, a year-on-year increase of 4.16%, while net profit attributable to shareholders was 39 million yuan, a year-on-year decrease of 33.11% [5][10] - The company adheres to the strategy of "strong brand in catering, large-scale food production," aiming to build a "large catering, large food, large brand" industrial pattern [5][10] - The company expects net profits attributable to shareholders for 2025-2027 to be 561 million, 634 million, and 692 million yuan respectively, corresponding to current price-earnings ratios of 17, 15, and 14 times [5][10] Summary by Sections Financial Performance - In Q2 2025, the company reported operating revenue of 945 million yuan, a year-on-year increase of 5.09%, with a net profit of -12 million yuan, continuing the loss trend [5][10] - The food manufacturing business saw a revenue increase of 2.65%, while the catering service business grew by 7.11% [10] - The overall revenue from the main business increased by 4.17% year-on-year [10] Business Strategy - The company is focusing on expanding new stores and entering new markets to enhance brand recognition [10] - It aims to innovate products and expand domestic and international channels through diversified marketing strategies [10] Market and Channel Development - The company is building a flexible and diverse channel system, emphasizing a "online + offline" collaborative strategy [10] - The food manufacturing business experienced strong growth outside Guangdong province, with a year-on-year revenue increase of 16.16% in regions outside Guangdong [10] Profitability and Cost Management - The gross profit margin decreased by 2.08 percentage points to 23.78% due to significant increases in credit impairment losses [10] - The overall period expense ratio decreased by 1.48 percentage points to 20.21%, indicating effective cost control [10]

Investment Rating - The report maintains a "Buy" rating for the company [2][6]. Core Views - In the short term, the company's performance is expected to be resilient due to the release of overseas production capacity and the growth of new customers in the automotive leather segment. In the long term, the expansion into the sports industry supply chain, having entered global brands like Adidas and VF, is anticipated to unlock growth and valuation potential. New businesses such as Hongxing and Baotai are positioned for high growth due to industry prosperity, contributing to the company's expected growth [2][5]. Financial Performance Summary - For the first half of 2025, the company achieved revenue of 1.34 billion yuan, a year-on-year increase of 6%, but the net profit attributable to the parent company decreased by 45% to 31 million yuan. In Q2 alone, revenue was 710 million yuan, with a similar year-on-year growth of 7%, while net profit dropped by 45% to 12 million yuan [4][5]. - By business segment, the main domestic sales were a drag on revenue, while automotive leather continued to show impressive growth. The shoe and bag segment saw a slight revenue decline of 0.1% to 850 million yuan, primarily due to weak domestic orders. In contrast, the automotive leather segment reported a 30% increase in revenue to 380 million yuan, driven by strong sales from core customers [5]. Profitability Insights - The overall gross margin in Q2 slightly decreased by 0.2 percentage points to 20.3%. The increase in management expenses and inventory impairment losses negatively impacted profits, with the net profit margin dropping by 1.7 percentage points to 1.7% [5]. Future Profit Forecast - The company forecasts net profits attributable to the parent company for 2025 to 2027 at 120 million, 160 million, and 190 million yuan, respectively, with year-on-year changes of -14%, +34%, and +19%. The corresponding price-to-earnings ratios are projected to be 32, 24, and 20 times [2][5].